RDNA-17. POWER DENSITY LOSS CAN BE USED TO DEFINED TUMOR TREATING FIELDS DOSE

Por Hershkovich, Hadas, Urman, Noa, Naveh, Ariel, Levi, Shay, Bomzon, Zeev
Publicado no Neuro Oncol (2018)

EXTH-76. OPTIMIZING TRANSDUCER ARRAY CONFIGURATION FOR TREATING TUMORS IN THE INFRATENTORIAL AND SUPRATENTORIAL BRAIN USING TUMOR TREATING FIELDS (TTFIELDS)

Por Levi, Shay, Naveh, Ariel, Bomzon, Ze’ev, Kirson, Eilon D, Weinberg, Uri
Publicado no Neuro Oncol (2017)

ACTR-91. NUMERICAL SIMULATIONS OF TTFIELDS DISTRIBUTION IN PATIENT MODELS REVEALS A CONNECTION BETWEEN FIELD INTENSITY AND PATIENT OUTCOME

Por Urman, Noa, Lavy-Shahaf, Gitit, Frenkel, Avital, Levi, Shay, Naveh, Ariel, Doron, Manzur, Wenger, Cornelia, Weinberg, Uri, Kirson, Eilon D, Bomzon, Ze’ev
Publicado no Neuro Oncol (2017)

NIMG-66. A METHOD FOR RAPIDLY CREATING HEAD MODELS OF GLIOBLASTOMA PATIENTS FOR STUDYING THE DELIVERY OF TTFIELDS TO THE BRAIN

Por Urman, Noa, Frenkel, Avital, Levi, Shay, Doron, Manzur, Naveh, Ariel, Hershkovich, Hadas Sara, Weinberg, Uri, Wenger, Cornelia, Kirson, Eilon D, Bomzon, Ze’ev
Publicado no Neuro Oncol (2017)